Optimising Systems and Processes of Wound Care - A QIPP resource of good practice. Developing and Implementing a Wound Care Prescribing Policy

Similar documents
Executive Summary points to consider by organisations providing Primary and Community Health services

Community Intravenous Therapy Referral Standards

Online Non-prescription Ordering Service (ONPOS) By Jayne Marie Lucas Senior Medicines Management Technician Central Essex Community Services

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

Masterclass: Introduction to wound management for pharmacists

CCG authorisation: the role of medicines management

JOB DESCRIPTION. Pharmacy Technician

5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?

Commissioning a Community IV service

TRUST BOARD 22 December Nursing, Quality & Patient Experience Directorate. TISSUE VIABILITY Update and Ambition

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

How to use NICE guidance to commission high-quality services

Wound Care and. February Lymphoedema Service

You requested information regarding wound care. Specifically you asked:

NHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP CLINICAL FUNDING AUTHORISATION POLICY

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide

Opportunities for partnership working between the NHS and the pharmaceutical industry in the Department of Health s innovation strategy

Quality summary report:

WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0

Delivering the QIPP programme: making existing services improve patient outcomes

Top Tips QIPP messages for prescribing dressings

NON-MEDICAL PRESCRIBING POLICY

Defining the Boundaries between NHS and Private Healthcare. MECCG Policy Reference: MECCG142

The PCT Guide to Applying the 10 High Impact Changes

Implementing bulk prescribing for care home patients

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

Improving patient outcomes: NHS England's workstream for the lower limb

Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH

UKMi and Medicines Optimisation in England A Consultation

Announcing the launch of the NICE BNF and NICE BNFC apps in Scotland, Sir Andrew Dillon, NICE Chief Executive, said:

Prevention and control of healthcare-associated infections

Guideline scope Intermediate care - including reablement

Care Bundle Wound Care Guidance

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY

NHS operational productivity: unwarranted variations Mental health services Community health services Lord Carter 24 May 2018

Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre

NICE Charter Who we are and what we do

Efficiency in mental health services

Utilisation Management

Pressure Ulcers The BHTA guide to prevention and cash releasing savings

Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services

An investigation into Lower Leg Ulceration in Northern Ireland

NHS and Private Interface Prescribing Guide

Wound Assessment: a case study approach

Medicines Management Strategy

Nurse prescribing in substance misuse February 2005, updated May 2005

Medicines Optimisation Strategy

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY

NHS Bradford Districts CCG Commissioning Intentions 2016/17

CCG Policy for Working with the Pharmaceutical Industry

GOVERNING BODY REPORT

Principles of Shared Care Protocols

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Supervising pharmacist independent

Final Report. Medicines Reconciliation Project Lead, Medicines Use and Safety - NHS

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

How NICE clinical guidelines are developed

NHS Clinical Reference Board and NHS Clinical Evaluation Team

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services

CCG GOVERNANCE BOARD EXECUTIVE SUMMARY SHEET

Title: Climate-HIV Case Study. Author: Keith Roberts

Methods: Commissioning through Evaluation

Topical Negative Pressure

WOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014

PGDs are permitted for use only by registered health professionals (see enclosed link for full list

Securing excellence in commissioning for the Armed Forces and their families. March 2013

Marginal Rate Emergency Threshold. Executive Summary

Best Practice Tariff: Early Inflammatory Arthritis

Commissioning for Value insight pack

Healthy lives, healthy people: consultation on the funding and commissioning routes for public health

North Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8

Review of Local Enhanced Services

Chapter 2. At a glance. What is health coaching? How is health coaching defined?

Please supply me with your most up to date wound care formulary (please indicate if you do not work from a formulary)?

Meeting in Common of the Boards of NHS England and NHS Improvement. 1. This paper updates the NHS England and NHS Improvement Boards on:

Bristol CCG North Somerset CGG South Gloucestershire CCG. Draft Commissioning Intentions for 2017/2018 and 2018/2019

Influences on you as a prescriber

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

Omitted and Delayed Medicines

Document Author: Tissue Viability Nurse Date 15/02/2017

Kevin McSorley, Service Delivery Director, TF3 Eddie Ritson, Programme Director, CCHC

NATIONAL HEALTH SERVICE, ENGLAND

The Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales.

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

The PCT Guide to Applying the 10 High Impact Changes. A guide from NatPaCT

CONSULTATION ON THE RE-PROCUREMENT OF THE NHS DIABETES PREVENTION PROGRAMME - FOR PRIMARY CARE AND LOCAL HEALTH ECONOMIES

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

JOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse

National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care in England. Core Values and Principles

A meeting of NHS Bromley CCG Governing Body 25 May 2017

REPORT TO CROYDON CLINICAL COMMISSIONING GROUP GOVERNING BODY Meeting in Public. 30 October 2012

THE VIRTUAL WARD MANAGING THE CARE OF PATIENTS WITH CHRONIC (LONG-TERM) CONDITIONS IN THE COMMUNITY

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST REDUCING HARM TISSUE VIABILITY PROGRESS REPORT

Physiotherapy outpatient services survey 2012

* At smith&nephew our products promote wellbeing which helps to reduce the human and economic cost of wounds. Abstracts Booklet

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

WORKING WITH THE PHARMACEUTICAL INDUSTRY

Factsheet for Healthcare Providers on the new Gluten-free Food Service by NHS Bedfordshire:

This SLA covers an enhanced service for care homes for older people and not any other care category of home.

Transcription:

East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Optimising ystems and Processes of Wound Care - A QIPP resource of good practice Background The total cost to the NH of caring for patients with wounds was estimated in 2005/2006 to represent around 3% of the total NH budget. The cost of dressings and wound care products contributes to this cost, but should not be focused on in isolation, as reducing the associated nursing time and wound-related hospitalisation are the most important factors contributing to the cost of wound care. In April 2012 The NPC published Prescribing of Dressings Guiding principles for improving the systems and processes for the supply and prescribing of wound dressings ( to document) which gives ten guiding principles focusing not only on wound management products but the whole wound care pathway. Aims of this Resource The aim of this resource is to collate examples of good practice around the guiding principles set out in the NPC document. Developing and Implementing a Wound Care Prescribing Policy The NPC guiding principles document (Principle 2) suggests that local health economies should develop (or adopt) a prescribing policy to increase productivity and to reduce wastage. It is acknowledged that part of this prescribing policy is the development and implementation of a dressings formulary. It has been estimated that 80% of patients can be treated using dressings from a limited list or formulary and that these documents support better patient outcomes. NICE has recently defined a local formulary as follows: A local formulary is the output of processes to support the managed introduction, utilisation or withdrawal of healthcare treatments within a health economy, service or organisation. In addition, NICE clarifies that when the term 'medicine' is used in the guidance it includes all healthcare treatments that may be considered in local formularies including wound care products. It follows then that the NICE Medicines practice guidelines - Developing and updating local formularies is applicable to wound care products. The development of a dressings formulary is a stepwise process which includes the following: 1. Product election 2. Formulary Development including the use of specialist products 3. Formulary Implementation

Medicines Use and afety It would appear that the best outcomes are as a result of collaborative working between Medicines Management and Tissue Viability services. The resources summarised below are given as examples of good practice to support this progression. Within the implementation section there are some examples which have been used within care homes this links to Principle 5 of the NPC guidance which mandates commissioners to work with care homes to provide a high standard of wound care in this setting. Contents 1. Product election... 3 1.1. Methodology to support the process of product selection and the control of entry of new products... 3 2. Formulary development... 5 2.1. Examples of wound care formularies... 5 2.2 Examples of how to control the use of specialist products... 7 3. Formulary Implementation... 8 3.1. Procurement and supply initiatives which assist formulary implementation... 8 3.2. Education and initiatives to support formulary implementation... 9 3.3. Commissioning another provider to manage the entire wound care service including formulary implementation... 10 East & outh East England pecialist Pharmacy ervices Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 2

Medicines Use and afety 1. Product election 1.1. Methodology to support the process of product selection and the control of entry of new products It is acknowledged that there is little high quality evidence to distinguish between dressings of a similar type and the NPC have suggested that it would seem appropriate for NH health professional to chose the least costly dressing of the type that meets the required characteristics. The examples of good practice given show how to ensure the process of product selection is defined and then consistently applied to support robust decision-making. Once a formulary has been established it is important to ensure that there is a continuous review to control the entry of new dressings onto the formulary. ome examples of resources to support this process are also given below. NICE Medicines practice guidelines - Developing and updating local formularies This guidance has been developed to support the NH in developing and updating local formularies. It provides sixteen broad good practice recommendations for the systems and processes needed to ensure NH organisations develop and update local formularies effectively and in accordance with statutory requirements. It clearly states that formularies for wound care products are covered by the guidance. Organisations should ensure that any processes used to develop wound care formularies are compliant with this guidance. Northern Ireland Pharmaceutical Clinical Effectiveness Programme A robust process for developing prescribing guidance and formulary chapters is used. A wound care formulary is available. to formulary Prioritisation framework NH Croydon has established a prioritisation framework to evaluate dressings and applies the same principles as those used when evaluating a drug for inclusion in their formulary. Product evaluation process Basingstoke, outhampton and Winchester District Prescribing Committee have developed a Dressing / Treatment Product Evaluation Form Nursing staff complete the evaluation form using the guidance given. These evaluations are then used as part of the evidence which is considered by the formulary group before a decision is made to include the product in the formulary. Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 3

Medicines Use and afety Evaluation of Wound Care Products and Wound Dressing Request Form outh West Yorkshire Wound Management Group has developed a standard wound product evaluation which is used when products are formally assessed. A form to be used to request the addition of a new item on the formulary is also given. to evaluation proforma to new dressing request form has comprehensive suite of resources tandard template to review wound care products Coastal West ussex has developed a template which guides staff through a series of questions to use when evaluating a product. These include clinical effectiveness, safety, patient factors and cost effectiveness. Proforma for new dressings NH Tayside has developed a proforma to support the inclusion of new dressings onto their formulary. Cumulative update to formulary Once a formulary has been published it can be difficult to make changes. The use of a cumulative update page has been successful in outhampton. Best Practice tatement: Development of a Formulary. Wounds UK, Aberdeen, 2008 Wounds UK has produced a guide to developing a wound formulary (with an educational grant from industry). It was published before the NICE guidance on formulary development, so may not be fully compliant. The section headings and statements may provide a useful starting point for organisations as they go through the process, but care should be taken to avoid those steps which have inappropriate inclusion of wound dressing company representatives. Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 4

Medicines Use and afety 2. Formulary development 2.1. Examples of wound care formularies Many organisations have developed wound care formularies and have agreed to share them; a selection is provided here. The formularies chosen for inclusion have shown either a robust development process or are an example of a different way of presenting the formulary. The majority of examples are from primary/community care where the formulary has been agreed across the interface. Examples of a secondary care, a tertiary care and a health economy wide wound care formulary are also given. Bedfordshire Wound Care Formulary This formulary is divided into four sections Dressings Tapes and skin care products Bandages Treatments for complex or difficult to heal wounds, including silvers, other antimicrobials and larvae therapy A process for evaluating a new dressing is given along with an evaluation form Croydon Primary & Community Care Wound Formulary Hampshire, outhampton and Portsmouth Wound Formulary This formulary for use across Primary and Community care includes recommended dressings and products for the management of wounds in Croydon. The choice of product is based upon a framework which includes the manufacturers instructions and research based evidence, and approved by Croydon Prescribing Committee. There is a section on substances which should no longer be used in wound cleansing with some evidence and rationale. This wound formulary has been agreed across the health economy. The purpose of the formulary is to provide a list of dressings, which based on the evidence available, should be selected for approximately 90% of prescribing in this area. There is a second line list of dressings which can only be used following strict criteria and completion of an Exception Reporting Form Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 5

Medicines Use and afety Wound Care Formulary from Inner North West London (Barnet) and Central London Community Healthcare This formulary which covers primary care and community services gives a first and second choice for dressings. In addition there is an Extended Tissue Viability Nurse Formulary for use only by the TVN service. (Primary Care) (Community Health ervices) Dressing Formulary Guidelines from West Essex PCT This formulary, used across primary care and community services, has been divided into colour coded sections which apply to either the classification of tissue in wounds or a particular speciality e.g. Leg Ulceration. The dressings within the formulary have been allocated a number indicating what the first preference should be. Clinicians should use the least costly products identified as 1 in the first instance and move to products identified as 2 or 3 if clinical evaluation of the wound indicates that the wound is failing to progress. The formulary is supported by comprehensive Wound Management Guidelines. Wound Management Formulary outh West Yorkshire health economy The formulary has been designed to meet the needs of both primary and secondary care. There are some variations between acute and primary care provision of products dependent upon appropriateness and availability. full text to dressing selection chart to dressings list has comprehensive suite of resources Wound care formulary for Addenbrookes Hospital Dressings formulary for Papworth Hospital NH Foundation Trust This wound care formulary has been developed for use in an acute trust This formulary has been developed for use in a tertiary care centre. Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 6

Medicines Use and afety 2.2 Examples of how to control the use of specialist products The most common way that organisations control the use of specialist products is by having a limited list which can only be used by higher level nurses or Tissue Viability Nurses. ome examples of this are given in ection 2.1. (above) along with the formulary examples, further examples are given below. ome organisations insist that an exception reporting form is used if a non-formulary product is to be used; some examples of these are also given below. Wound Healing Products- Formulary and Guidelines from Aneurin Bevan Health Board This formulary provides on a definitive list of dressings which are available in primary and secondary care. The formulary consists of a three tables Table 1 - freely available Table 2 - only available if authorised by the TVN or Community Band 7+. Table 3 - only available if authorised by TVN Where a non-formulary item is required an application must be made to the Health Board. to formulary and guidelines to authorisation form for table 2 and 3 dressings to application form to use a nonformulary item Wound Management Formulary Devon health economy This is a web-based formulary based on BNF chapters. It gives guidance for primary and secondary care and includes first line, second line and specialist only choices using a traffic light system. (outh & West) (North & East) Devon Formularies NH Tayside pecialist Dressings This section of the NH Tayside wound formulary has dressings that can be used only on the direction of a specialist in secondary care. Non-specialist practitioners wishing to use the dressings listed in this section out with specialist advice should complete a Non-formulary Dressing Reporting Form. to pecialist Dressings section to Nonformulary reporting form Hampshire, outhampton and Portsmouth Exception Reporting Form Completion of an exception reporting form is a mandatory requirement when prescribing off formulary. These forms are also used to guide what products are evaluated for future formulary inclusion. Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 7

Medicines Use and afety Dressing Exception Form for East Lancashire health economy This dressing exception form is to be completed if a dressing is used which is not listed in the Wound Care Formulary. This is used to monitor compliance and when reviewing the existing formulary. Non Formulary Exception Reporting Form used by outh West Yorkshire health economy This form is to be completed when a non-formulary product is to be used. The form is also used to help monitor the appropriateness of the present formulary and influence future decision-making. pecialist only list used in Greenwich If a specialist product is required then the patient must be assessed by Integrated Complex Wound Care Team. A proforma is completed and sent to the GP to prescribe them on an FP10. 3. Formulary Implementation Incentivising formulary implementation is a useful process that commissioners can employ. This is covered in a separate resource 3.1. Procurement and supply initiatives which assist formulary implementation ome organisations have chosen to limit the access to dressings by the procurement route, thus ensuring that only the items on the formulary are available for selection. Other organisations have chosen to use prepared prescription form lists which are sent to GP practices to order dressings; these limit choices to those items on the formulary. NH upply Chain Using NH supply chain as the procurement option allowed compliance with the organisation s formulary Use of ONPO Central Essex Community services have found that using an Online Non-prescription Ordering ervice (ONPO) increased formulary compliance from <40% to > 90% NH urrey and urrey Community Health use ONPO to restrict access to their formulary which is divided into three parts: Nursing Home Practice Nurse Community Nurse. Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 8

Medicines Use and afety Dressing Request Forms A number of organisations have implemented a dressings request form which is used to order drugs from the GP practice. The preprinted form ensures that formulary only drugs are selected. A selection of examples is given. ome specific examples for use in care homes are given 3.2. Education and initiatives to support formulary implementation To ensure wound care formularies are implemented in organisations it is vital that there is an education and sharing programme. ome examples of how this has been tackled in organisations are shared below. Wound Management Guidelines West Essex has produced a comprehensive set of wound management guidelines which complement their formulary. It also contains a competency assessment which includes a selfassessment and a competency framework. Northern Ireland Wound Care Formulary Along with the formulary there is a useful assessment tool to initially evaluate the wound and then record treatment progression. The acronym B.E...O.P. is used: Bed, Exudate, ite, ize, urrounding kin, Odour, Pain Wound Management Formulary and Educational Resource Book This resource has been developed in Bradford; it aims to bring together the knowledge that underpins current wound care practice and links this to a locally agreed product formulary. Wound Management Guidance Both outh & West and North & East Devon have comprehensive wound management guidance (outh & West) (North & East) Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 9

Medicines Use and afety ummary leaflet for nurses outh West Yorkshire health economy has developed a summary leaflet for nurses as an aide memoire; it folds into an A5 leaflet that fits into a diary. Newsletters Central London Community Healthcare has developed a joint medicines management and tissue viability newsletter, which aims to ensure up to date reaches practitioners and reminds staff about formulary choices. 3.3. Commissioning another provider to manage the entire wound care service including formulary implementation Accelerate CIC Partners in Wound and Lymphoedema Care Commissioned by Tower Hamlets to manage the wound care pathway which involves overseeing the centralised dressing scheme (which includes managing the dressings budget) The service offers: 90% of prescribing dressing costs within wound care budget, managed by the provider on behalf of all DN teams, GP Practices and Nursing Homes Chronic wounds assessed early by provider, thus reducing need for silver and antimicrobial dressings Prompt referral to the provider s specialist wound and lymphoedema service improves healing thereby reduces cost/spend The provider s specialist service accesses any product they require. et dressing list for generic staff but enhanced with special orders when required for varying patient need Developing and Implementing a Wound Care Prescribing Policy Vs1.2 December 2012 (TR) 10